All data are based on the daily closing price as of March 2, 2026
e
Eiken Chemical
4549.TSE
19.99 USD
-0.11
-0.55%
Overview
Last close
19.99 usd
Market cap
659.20M usd
52 week high
21.17 usd
52 week low
13.47 usd
Target price
13.39 usd
Valuation
P/E
20.106
Forward P/E
N/A
Price/Sales
2.504
Price/Book Value
2.3664
Enterprise Value
649.83M usd
EV/Revenue
2.4706
EV/EBITDA
13.5524
Key financials
Revenue TTM
263.03M usd
Gross Profit TTM
106.36M usd
EBITDA TTM
34.62M usd
Earnings per Share
0.75 usd
Dividend
0.36 usd
Total assets
384.45M usd
Net debt
-18.65M usd
About
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.